Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Chengappa, KN Roy
Baker, Robert W
Shao, Lixin
Yatham, Lakshmi N
Tohen, Mauricio
Gershon, Samuel
and
Kupfer, David J
2003.
Rates of response, euthymia and remission in two placebo‐controlled olanzapine trials for bipolar mania.
Bipolar Disorders,
Vol. 5,
Issue. 1,
p.
1.
Fagiolini, Andrea
and
Kupfer, David J
2003.
Is treatment-resistant depression a unique subtype of depression?.
Biological Psychiatry,
Vol. 53,
Issue. 8,
p.
640.
Swartz, Holly A.
Frank, Ellen
Spielvogle, Heather N.
and
Kupfer, David J.
2004.
Mood Disorders.
p.
275.
Vieta, Eduard
2005.
The treatment of mixed states and the risk of switching to depression.
European Psychiatry,
Vol. 20,
Issue. 2,
p.
96.
Berk, Michael
Dodd, Seetal
and
Malhi, Gin S.
2005.
‘Bipolar Missed States’: The Diagnosis and Clinical Salience of Bipolar Mixed States.
Australian & New Zealand Journal of Psychiatry,
Vol. 39,
Issue. 4,
p.
215.
Thase, Michael E.
2005.
Bipolar Depression: Issues in Diagnosis and Treatment.
Harvard Review of Psychiatry,
Vol. 13,
Issue. 5,
p.
257.
Berk, Michael
Dodd, Seetal
and
Malhi, Gin S.
2005.
'Bipolar missed states': the diagnosis and clinical salience of bipolar mixed states.
Australian and New Zealand Journal of Psychiatry,
Vol. 39,
Issue. 4,
p.
215.
Roy Chengappa, KN
Hennen, John
Baldessarini, Ross J
Kupfer, David J
Yatham, Lakshmi N
Gershon, Samuel
Baker, Robert W
and
Tohen, Mauricio
2005.
Recovery and functional outcomes following olanzapine treatment for bipolar I mania.
Bipolar Disorders,
Vol. 7,
Issue. 1,
p.
68.
2005.
Handbook of Bipolar Disorder.
p.
179.
Swartz, Holly A
Pilkonis, Paul A
Frank, Ellen
Proietti, Joseph M
and
Scott, John
2005.
Acute treatment outcomes in patients with bipolar I disorder and co‐morbid borderline personality disorder receiving medication and psychotherapy.
Bipolar Disorders,
Vol. 7,
Issue. 2,
p.
192.
Thase, Michael E.
2006.
Pharmacotherapy of bipolar depression: An update.
Current Psychiatry Reports,
Vol. 8,
Issue. 6,
p.
478.
Sachs, Gary
Sanchez, Raymond
Marcus, Ronald
Stock, Elyse
Mcquade, Robert
Carson, William
Abou-Gharbia, Neveen
Impellizzeri, Cheryl
Kaplita, Stephen
Rollin, Linda
and
Iwamoto, Taro
2006.
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.
Journal of Psychopharmacology,
Vol. 20,
Issue. 4,
p.
536.
THASE, MICHAEL E.
2006.
Bipolar depression: Diagnostic and treatment considerations.
Development and Psychopathology,
Vol. 18,
Issue. 04,
2006.
Speaker Abstracts.
International Journal of Psychiatry in Clinical Practice,
Vol. 10,
Issue. 4,
p.
306.
Miklowitz, David J.
2006.
An update on the role of psychotherapy in the management of bipolar disorder.
Current Psychiatry Reports,
Vol. 8,
Issue. 6,
p.
498.
Berk, Michael
Conus, Philippe
Lucas, Nellie
Hallam, Karen
Malhi, Gin S
Dodd, Seetal
Yatham, Lakshmi N
Yung, Alison
and
McGorry, Pat
2007.
Setting the stage: from prodrome to treatment resistance in bipolar disorder.
Bipolar Disorders,
Vol. 9,
Issue. 7,
p.
671.
Grunze, Heinz
and
Forsthoff, Anna
2008.
Handbuch der Psychopharmakotherapie.
p.
555.
Geddes, John R.
Calabrese, Joseph R.
and
Goodwin, Guy M.
2009.
Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials.
British Journal of Psychiatry,
Vol. 194,
Issue. 1,
p.
4.
Grunze, Heinz
Vieta, Eduard
Goodwin, Guy M.
Bowden, Charles
Licht, Rasmus W.
Möller, Hans-Jürgen
and
Kasper, Siegfried
2010.
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
The World Journal of Biological Psychiatry,
Vol. 11,
Issue. 2,
p.
81.
Woodward, Tatia Chay
Tafesse, Eskinder
Quon, Peter
and
Lazarus, Arthur
2010.
Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder.
PharmacoEconomics,
Vol. 28,
Issue. 9,
p.
751.